®()

Saxenda ®(Liraglutide)

Prescription Only

Saxenda (liraglutide) is used to aid weight loss and maintain weight reduction in adults dealing with obesity or overweight issues along with weight-related medical conditions....

Dosage & Administration

Administration

Learn more.

Subcutaneous. Learn more.

Dosing

Learn more.

The recommended dose of SAXENDA® is 3 mg daily. Initiate at 0.6 mg per day for one week. In weekly intervals, increase the dose until a dose of 3 mg is reached.. Learn more.

Latin Shorthand

Learn more.

3 mg daily. Start: 0.6 mg/day for 1 week. Weekly increments to reach 3 mg dosage.. Learn more.

Financial Assistance

Out-Of-Pocket Costs With Copay Card

Learn more.

Annual Cap

Learn more.

Assistance Expiration

Learn more.

Generics

No lower-cost generic available

Physician Advisory

Adverse Reactions

Learn more.

Most common adverse reactions, reported in greater than or equal to 5% are: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, increased lipase, upper abdominal pain, pyrexia, and gastroenteritis. . Learn more.

Mechanism of Actions (MoA)

Learn more.

GLP-1 Receptor Agonists. Learn more.

Special Populations

Is SAXENDA® safe during pregnancy?

SAXENDA® is contraindicated during pregnancy as weight loss offers no benefit and may harm the fetus. There's limited data on its use in pregnant women.

What do animal studies reveal about liraglutide's effects during pregnancy?

Animal studies have shown increased adverse effects on embryofetal development due to liraglutide exposure during pregnancy, indicating potential harm.

Are there data on the use of SAXENDA® during lactation?

There's no data on the presence of liraglutide in human milk, but it was detected in lactating rat milk. Consider breastfeeding benefits and potential risks of SAXENDA® for both mother and infant.

Is SAXENDA® approved for pediatric use?

SAXENDA® is approved for pediatric patients aged 12 years and older with obesity, supported by clinical trials. However, some adverse events were reported in these trials.

How does SAXENDA® perform in geriatric patients?

In clinical trials, no significant differences were observed in safety or effectiveness between older and younger patients. However, caution is advised in the elderly.

What precautions should be taken for patients with renal impairment using SAXENDA®?

Limited experience exists for SAXENDA® in patients with renal impairment. There have been reports of renal failure, necessitating caution in this population.

How about the use of SAXENDA® in patients with hepatic impairment?

Limited experience exists for SAXENDA® in patients with hepatic impairment, indicating caution in this patient population.

Is SAXENDA® suitable for patients with pre-existing gastroparesis?

SAXENDA® has not been studied in patients with pre-existing gastroparesis.

®()	Saxenda ®(Liraglutide)

Prescription Only	Prescription Only Saxenda (liraglutide) is used to aid weight loss and maintain weight reduction in adults dealing with obesity or overweight issues along with weight-related medical conditions....
Dosage & Administration	Dosage & Administration comparison data
Administration
Learn more.	Subcutaneous. Learn more.
Dosing
Learn more.	The recommended dose of SAXENDA® is 3 mg daily. Initiate at 0.6 mg per day for one week. In weekly intervals, increase the dose until a dose of 3 mg is reached.. Learn more.
Latin Shorthand
Learn more.	3 mg daily. Start: 0.6 mg/day for 1 week. Weekly increments to reach 3 mg dosage.. Learn more.
Financial Assistance	Financial Assistance comparison data
Out-Of-Pocket Costs With Copay Card
Learn more.	Learn more.
Annual Cap
Learn more.	Learn more.
Assistance Expiration
Learn more.	Learn more.
Generics
No lower-cost generic available	No lower-cost generic available
Physician Advisory	Physician Advisory comparison data
Adverse Reactions
Learn more.	Most common adverse reactions, reported in greater than or equal to 5% are: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, increased lipase, upper abdominal pain, pyrexia, and gastroenteritis. . Learn more.
Mechanism of Actions (MoA)
Learn more.	GLP-1 Receptor Agonists. Learn more.
Special Populations
	Is SAXENDA® safe during pregnancy? SAXENDA® is contraindicated during pregnancy as weight loss offers no benefit and may harm the fetus. There's limited data on its use in pregnant women. What do animal studies reveal about liraglutide's effects during pregnancy? Animal studies have shown increased adverse effects on embryofetal development due to liraglutide exposure during pregnancy, indicating potential harm. Are there data on the use of SAXENDA® during lactation? There's no data on the presence of liraglutide in human milk, but it was detected in lactating rat milk. Consider breastfeeding benefits and potential risks of SAXENDA® for both mother and infant. Is SAXENDA® approved for pediatric use? SAXENDA® is approved for pediatric patients aged 12 years and older with obesity, supported by clinical trials. However, some adverse events were reported in these trials. How does SAXENDA® perform in geriatric patients? In clinical trials, no significant differences were observed in safety or effectiveness between older and younger patients. However, caution is advised in the elderly. What precautions should be taken for patients with renal impairment using SAXENDA®? Limited experience exists for SAXENDA® in patients with renal impairment. There have been reports of renal failure, necessitating caution in this population. How about the use of SAXENDA® in patients with hepatic impairment? Limited experience exists for SAXENDA® in patients with hepatic impairment, indicating caution in this patient population. Is SAXENDA® suitable for patients with pre-existing gastroparesis? SAXENDA® has not been studied in patients with pre-existing gastroparesis.

® Alternatives